Up
2006P-0201:
Cefotan (cefotetan injection), Equivalent 1 g base/vial and 2 g
base/vial, Manufactured by AstraZeneca has been Voluntarily Withdrawn
from Sale for Safety and Efficacy Reasons
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| CP1
|
| 05/11/2006
|
| 05/11/2006
|
| Drug Industry
|
| B. Braun Medical Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Susan Olinger
|
|
|
| ACK1
|
| 05/11/2006
|
| 05/11/2006
|
| Federal Government
|
| HFA-305 to B. Braun
Medical Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
Top | Up
Page last updated
June 30, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |